Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional Scores

PURPOSE: Neoadjuvant immunotherapy and chemotherapy (nICT) is an emerging hotspot that has been shown to be safe and feasible for locally advanced esophageal squamous cell carcinoma (LA-ESCC). This real-world study aimed to develop and validate a novel predictive model [integrative inflammatory and...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jifeng, Wang, Liang, Yang, Xun, Chen, Qixun, Cheng, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271687/
https://www.ncbi.nlm.nih.gov/pubmed/35832830
http://dx.doi.org/10.2147/JIR.S367964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271687/
https://www.ncbi.nlm.nih.gov/pubmed/35832830
http://dx.doi.org/10.2147/JIR.S367964

Ejemplares similares